Early Closure – In-Service Training

ATTENTION: HealthWell Foundation’s hotline will close at 3:30 p.m. on Wednesday, May 18, 2022 due to in-service training and will re-open on Thursday, May 19, 2022 at 9:00 a.m. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time.  Please note: if you are contacting us about a payment or grant, please email us at grants@healthwellfoundation.org and a representative will respond to your message as quickly as possible when our offices re-open.  We apologize for any inconvenience and look forward to serving you. The HealthWell Team

Dismiss alert
By Real World Health Care Editorial Staff  |  Feb 23, 2022

11 Myths About Alzheimer’s Disease

Alzheimer’s disease is a leading cause of death in the United States and millions of Americans are affected by the disease. It’s important to distinguish the facts from the myths about Alzheimer’s, especially when it comes to finding information online. The following information about common myths surrounding Alzheimer’s was originally…more.

Categories: Alzheimer's Disease
By Krista Zodet, President, HealthWell Foundation  |  Jan 12, 2022

Ahead in 2022: Health Equity and Chronic Diseases in the Spotlight

As I sat down to write my year-end column for 2021, I was struck by how much had changed over the course of the year…and how much remains the same. Thanks to the efforts of brilliant scientists, dedicated clinicians and determined citizens, we now have readily available vaccines (and boosters)…more.

Categories: General
By Real World Health Care Editorial Staff  |  Jan 24, 2018

Patient Agitation in Alzheimer’s Disease: Implications for Patients and Caregivers

In March, Real World Health Care will launch a new series focusing on the behavioral health impacts of chronic illnesses. Until then, we will revisit a few of our recent blog posts that touch briefly on related behavioral health issues. This week, we feature our interview with Anton Porsteinsson, MD, Department…more.

By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Jul 20, 2016

Attacking All Angles of Alzheimer’s

Editor’s Note: This article originally appeared in Biotech Primer Weekly. For more information on the science behind the headlines, please subscribe. Alzheimer’s disease ranks as one of the toughest nuts to crack within drug discovery and development. Current treatments merely manage symptoms, so finding a better solution becomes more and…more.

By Raymond Scott Turner, MD, PhD, Professor of Neurology, Georgetown University  |  Jul 6, 2016

Dr. R. Scott Turner on Resveratrol and the Amyloid Hypothesis

This week, we sit down with R. Scott Turner, MD, PhD, Professor of Neurology at Georgetown University and Director of Georgetown’s Memory Disorders Program. Dr. Turner specializes in cognitive behavioral neurology, memory disorders, Alzheimer’s disease and Neurodegenerative dementias. Here, he discusses his latest research as well as the roles of…more.

By Anton Porsteinsson, MD, University of Rochester School of Medicine  |  Jun 22, 2016

Patient Agitation in Alzheimer’s Disease: Implications for Patients and Caregivers

Real World Health Care recently sat down with Anton Porsteinsson, MD, Department of Psychiatry, University of Rochester School of Medicine. Dr. Porsteinsson is the Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program and has devoted his career to the care and study of individuals with…more.

By Diane Bovenkamp, Ph.D., Chief Scientific Officer, BrightFocus Foundation  |  May 25, 2016

BrightFocus Foundation Leaving No Stone Unturned in Fight against Alzheimer’s

This week, Real World Health Care talks with Diane Bovenkamp, Ph.D., Chief Scientific Officer for BrightFocus Foundation about the basic science and therapeutic research the Foundation is funding. Dr. Bovenkamp administers and ensures a high level of scientific accountability in the foundation’s research grant award program and scientific review process,…more.

By Creighton Phelps, Ph.D., acting director, Division of Neuroscience, National Institute on Aging, National Institutes of Health  |  May 11, 2016

National Institute on Aging Outlines Alzheimer’s Priorities

As part of our series on Alzheimer’s Disease, Real World Health Care spoke with Creighton Phelps, Ph.D., acting director, Division of Neuroscience, National Institute on Aging, National Institutes of Health. Dr. Phelps discusses the challenges facing AD researchers and how the NIA is working to overcome them. Real World Health…more.

By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Apr 27, 2016

The Central Nervous System: A Brief Primer

The central nervous system (CNS) consists of the brain and the spinal cord. It sends and receives information from the peripheral nervous system—the vast network of nerves that feed into every tissue of the body. These signals enable voluntary and involuntary movement, and allow the brain to process and interpret…more.

By Real World Health Care Editorial Staff  |  Apr 21, 2016

New Series to Launch: Alzheimer’s Disease and the Central Nervous System

According to a report from the Alzheimer’s Foundation of America, as many as 5.1 million Americans may have Alzheimer’s Disease (AD), a figure that is expected to triple to nearly 13.8 million by 2050. Alzheimer’s is the sixth leading cause of death in America, and individuals with AD use a…more.

Close menu